In order to investigate a downstream component of the IL-23 pathway, Takedatsu et al. determined whether a mAb to the IL-23 receptor (IL-23R) attenuated indices of acute or chronic-DSS-induced colitis in mice [16]. Here, IL23R is linked to colitis.